The development of theory-informed participant-centred interventions to maximise participant retention in randomised controlled trials.
Behaviour
Clinical trials
Intervention development
Retention
Theory
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
08 Apr 2022
08 Apr 2022
Historique:
received:
17
09
2021
accepted:
26
03
2022
entrez:
9
4
2022
pubmed:
10
4
2022
medline:
13
4
2022
Statut:
epublish
Résumé
A failure of clinical trials to retain participants can influence the trial findings and significantly impact the potential of the trial to influence clinical practice. Retention of participants involves people, often the trial participants themselves, performing a behaviour (e.g. returning a questionnaire or attending a follow-up clinic as part of the research). Most existing interventions that aim to improve the retention of trial participants fail to describe any theoretical basis for the potential effect (on behaviour) and also whether there was any patient and/or participant input during development. The aim of this study was to address these two problems by developing theory- informed, participant-centred, interventions to improve trial retention. This study was informed by the Theoretical Domains Framework and Behaviour Change Techniques Taxonomy to match participant reported determinants of trial retention to theoretically informed behaviour change strategies. The prototype interventions were described and developed in a co-design workshop with trial participants. Acceptability and feasibility (guided by (by the Theoretical Framework of Acceptability) of two prioritised retention interventions was explored during a focus group involving a range of trial stakeholders (e.g. trial participants, trial managers, research nurses, trialists, research ethics committee members). Following focus group discussions stakeholders completed an intervention acceptability questionnaire. Eight trial participants contributed to the co-design of the retention interventions. Four behaviour change interventions were designed: (1) incentives and rewards for follow-up clinic attendance, (2) goal setting for improving questionnaire return, (3) participant self-monitoring to improve questionnaire return and/or clinic attendance, and (4) motivational information to improve questionnaire return and clinic attendance. Eighteen trial stakeholders discussed the two prioritised interventions. The motivational information intervention was deemed acceptable and considered straightforward to implement whilst the goal setting intervention was viewed as less clear and less acceptable. This is the first study to develop interventions to improve trial retention that are based on the accounts of trial participants and also conceptualised and developed as behaviour change interventions (to encourage attendance at trial research visit or return a trial questionnaire). Further testing of these interventions is required to assess effectiveness.
Sections du résumé
BACKGROUND
BACKGROUND
A failure of clinical trials to retain participants can influence the trial findings and significantly impact the potential of the trial to influence clinical practice. Retention of participants involves people, often the trial participants themselves, performing a behaviour (e.g. returning a questionnaire or attending a follow-up clinic as part of the research). Most existing interventions that aim to improve the retention of trial participants fail to describe any theoretical basis for the potential effect (on behaviour) and also whether there was any patient and/or participant input during development. The aim of this study was to address these two problems by developing theory- informed, participant-centred, interventions to improve trial retention.
METHODS
METHODS
This study was informed by the Theoretical Domains Framework and Behaviour Change Techniques Taxonomy to match participant reported determinants of trial retention to theoretically informed behaviour change strategies. The prototype interventions were described and developed in a co-design workshop with trial participants. Acceptability and feasibility (guided by (by the Theoretical Framework of Acceptability) of two prioritised retention interventions was explored during a focus group involving a range of trial stakeholders (e.g. trial participants, trial managers, research nurses, trialists, research ethics committee members). Following focus group discussions stakeholders completed an intervention acceptability questionnaire.
RESULTS
RESULTS
Eight trial participants contributed to the co-design of the retention interventions. Four behaviour change interventions were designed: (1) incentives and rewards for follow-up clinic attendance, (2) goal setting for improving questionnaire return, (3) participant self-monitoring to improve questionnaire return and/or clinic attendance, and (4) motivational information to improve questionnaire return and clinic attendance. Eighteen trial stakeholders discussed the two prioritised interventions. The motivational information intervention was deemed acceptable and considered straightforward to implement whilst the goal setting intervention was viewed as less clear and less acceptable.
CONCLUSIONS
CONCLUSIONS
This is the first study to develop interventions to improve trial retention that are based on the accounts of trial participants and also conceptualised and developed as behaviour change interventions (to encourage attendance at trial research visit or return a trial questionnaire). Further testing of these interventions is required to assess effectiveness.
Identifiants
pubmed: 35395930
doi: 10.1186/s13063-022-06218-8
pii: 10.1186/s13063-022-06218-8
pmc: PMC8994320
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
268Subventions
Organisme : Chief Scientist Office
ID : HSRU1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L01193X/1
Pays : United Kingdom
Organisme : Health Research Board
ID : Trial Methodology Research Network
Pays : Ireland
Organisme : Chief Scientist Office, Scottish Government Health and Social Care Directorate
ID : HIPS/16/46
Informations de copyright
© 2022. The Author(s).
Références
BMJ Open. 2022 Mar 9;12(3):e054854
pubmed: 35264354
BMJ Open. 2017 Mar 20;7(3):e015276
pubmed: 28320800
Trials. 2019 Oct 7;20(1):578
pubmed: 31590694
Trials. 2014 Jan 23;15:32
pubmed: 24456928
BMC Health Serv Res. 2017 Jan 26;17(1):88
pubmed: 28126032
Trials. 2020 Aug 1;21(1):694
pubmed: 32738919
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
J Clin Epidemiol. 2021 Sep;137:1-13
pubmed: 33727134
Support Care Cancer. 2015 Oct;23(10):3069-80
pubmed: 25744288
Implement Sci. 2019 Dec 5;14(1):102
pubmed: 31806037
Trials. 2019 Oct 15;20(1):593
pubmed: 31615577
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Cochrane Database Syst Rev. 2021 Mar 6;3:MR000032
pubmed: 33675536
BMJ Open. 2021 Mar 19;11(3):e043929
pubmed: 33741670
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
BMJ Open. 2019 Jun 3;9(6):e021959
pubmed: 31164359
Health Psychol. 2020 Dec;39(12):1048-1061
pubmed: 32658498
Lancet. 2011 Jul 2;378(9785):49-55
pubmed: 21722952
Trials. 2021 Mar 25;22(1):230
pubmed: 33766105
Curr Oncol. 2021 May 26;28(3):2014-2028
pubmed: 34073279
J Clin Epidemiol. 2020 Jun;122:35-41
pubmed: 32027931
Trials. 2018 Mar 27;19(1):197
pubmed: 29580260
Implement Sci. 2012 Apr 24;7:37
pubmed: 22530986